相关人员
Dr. Stefanie Greifeneder
Stefanie is an expert in all regulatory, commercial and contractual matters in the pharmaceutical, medical device and biotech sector as well as in compliance-relevant topics in this area. She advises on the drafting and negotiation of complex and cross-border licensing agreements (out-licensing and in-licensing), research and development collaborations, manufacturing and distribution agreements as well as clinical trial agreements and with CROs.
In M&A and private equity transactions in the life sciences sector, she advises on all regulatory and contractual issues.
显示完整简历
隐藏完整简历
更多
显示更少
更多
显示更少
职业发展
| Since 2023 | Partner, Taylor Wessing |
| 2013 - 2023 | Partner, Fieldfisher, Munich |
| 2012 - 2013 | Counsel, Salans LLP, Frankfurt am Main |
| 2010 - 2012 | Senior Associate, Raupach, Frankfurt am Main |
| 2004 - 2009 | Associate, Ashurst LLP, Munich |
教育
| 2004 - 2008 | Doctoral degree, dissertation on „Health and Nutrition Claims on Foods“ |
| 2004 | Admission as a lawyer |
| 2004 | Second State Examination, Munich |
| 2002 | First State Examination, Munich |
| 1997 - 2002 | Legal Studies at Ludwig-Maximilians-University Munich |
语言
| English |
最新新闻和观点
酒店与休闲
点击此处了解更多
R&D Collaborations | Coffee Break Life Sciences Start-ups #4
2024年4月18日
In-depth analysis
专利与创新
点击此处了解更多
Important for start-ups: Confidentiality Agreements and Material Transfer Agreements (MTAs)
2024年3月27日
Briefing
公司/并购与资本市场
点击此处了解更多
Bertelsmann Investments acquires pharma tech company EXTEDO with Taylor Wessing
2024年2月27日
作者
酒店与休闲
点击此处了解更多
Your safe path through the contract jungle: CDAs, MTAs & Co. | Coffee Break Life Sciences Start-ups #1
2024年1月30日
In-depth analysis